JPRN-UMIN000042980Completed未知
Mixed hepatocellular carcinoma and cholangiocarcinoma in liver transplantation: Prognostic factors for outcomes in Korea-Japan multicenter study - Mixed hepatocellular carcinoma and cholangiocarcinoma in liver transplantation: Prognostic factors for outcomes in Korea-Japan multicenter study
Japanese Society of Hepato-Biliary-Pancreatic Surgery0 sites18 target enrollmentStarted: January 20, 2021Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 18
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Pathologically proven HCC or intrahepatic CCC after liver transplantation.
Investigators
Similar Trials
Recruiting
Phase 2
Hepatocellular carcinoma: vascular abnormalities prior to, during and following systemic anti-cancer treatment10019815liver cancerNL-OMON32482eids Universitair Medisch Centrum28
Active, not recruiting
Not Applicable
Hepatocellular carcinoma: vascular abnormalities prior to, during and following systemic anti-cancer treatment - everolimus and capecitabine for HCCEUCTR2008-003972-23-NLMC
Completed
Not Applicable
Incidence of hepatocellular caricinoma and B-cell non-Hodgkin lymphoma in chronic hepatitis C.Hepatitis CJPRN-C000000226Ikeda Municipal Hosital850
Enrolling By Invitation
Not Applicable
Comparison between using hepatocellular carcinoma (HCC) risk scores and current criteria to identify chronic hepatitis B patients needing HCC surveillance-Compare between the use of HCC risk scores and current criteria to identify HCC high risk in chronic hepatitis B patients -Role the HCC risk scores to identify HCC high risk in chronic hepatitis BTCTR20200827002one201
Completed
Not Applicable
Combined HCC-MFCCCLiver CarcinomaHepatocellular CarcinomaSurgeryCholangiocarcinomaNCT03178409University of Milan100